TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Redo Biosolutions AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
149,969
|
124,300
|
60,294 |
Financial expenses |
2
|
7
|
4 |
Earnings before taxes |
26,296
|
24,650
|
-1,096 |
EBITDA |
30,452
|
27,517
|
713 |
Total assets |
110,324
|
78,830
|
40,042 |
Current assets |
80,341
|
47,164
|
26,115 |
Current liabilities |
39,567
|
33,428
|
15,279 |
Equity capital |
69,310
|
45,403
|
24,763 |
- share capital |
101
|
95
|
98 |
Employees (average) |
4
|
3
|
0 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
62.8%
|
57.6%
|
61.8% |
Turnover per employee |
37,492
|
41,433 | |
Profit as a percentage of turnover |
17.5%
|
19.8%
|
-1.8% |
Return on assets (ROA) |
23.8%
|
31.3%
|
-2.7% |
Current ratio |
203.1%
|
141.1%
|
170.9% |
Return on equity (ROE) |
37.9%
|
54.3%
|
-4.4% |
Change turnover |
16,849
|
65,818
|
8,714 |
Change turnover % |
13%
|
113%
|
17% |
Chg. No. of employees |
1
|
3
|
0 |
Chg. No. of employees % | 33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.